IF INFORMED CONSENT IS AN ONGOING PROCESS, WHAT DOES RE-CONSENT MEAN?

Informed consent is a fundamental ethical requirement in clinical research. It is more than signing a form; it is also a process. Information must be presented in a way to enable an individual to voluntarily decide whether to participate in a research study. This information exchange occurs between the Investigator, research team, and the participant, but may lack documentation to support the research participant’s informed decision to continue participation based on the information exchange.

By the end of this session, the learner will be able to:

1. Define re-consent and reaffirmation.
2. Explain three types of research situations that warrant participant re-consenting.
3. Discuss the clinical research nursing implications for re-consenting research participants.

Presented by:

Sharon Flynn, RN, MS, ANP-BC, AOCNS, BMTCN Nurse Practitioner Clinical Center Nursing Department National Institutes of Health Bethesda, MD

Elizabeth Ness, MS, BSN, RN Director, Office of Education and Compliance Center for Cancer Research, National Cancer Institute National Institutes of Health Bethesda, MD

For more information Click Here!

For Nurse Attendees:

IACRN will be providing their members FREE contact hours, non-IACRN members can purchase contact hours for $10. After the webinar, nurses will receive an email from IACRN outlining instructions to complete the evaluation and receive the contact hours. To receive full contact-hour credit (one contact hour) for this CNE activity, you must: be registered, attend at least 80% of the webinar, and complete an on-line evaluation.